Market by Animal Type, Distribution Channel, Route of Administration, Product, and Geography | Forecast 2019-2028
The detailed analysis of the global veterinary medicines market by Triton Market Research displays that, in terms of revenue, the market is expected to develop at a CAGR of 4.11% during the estimated years of 2019-2028. The market attained $22.89 billion in 2019, and is likely to garner $32.89 billion by 2028.
Report scope can be customized per your requirements. Request For Customization
Veterinary medicine is well-defined as a drug that is employed in animal treatment. The surge in the number of pet owners and a rise in the livestock, are significant factors contributing to the development of the veterinary medicines market. Additionally, the increase in the incidence of multiple medical conditions in animals and the elevated demand for livestock products is also boosting the growth of the veterinary medicines market.
Furthermore, several veterinary establishments worldwide have recommended limiting patient care to extremely ill animals, rescheduling annual exams, and elective procedures. This has resulted in the downfall in demand for veterinary medicines, owing to the coronavirus outbreak.
Triton’s study aims to get an overview of the veterinary medicine market relating to several factors. The detailed analysis of the market includes the key insight, market description, industry components, Porter’s five forces model, legal, policy and regulatory framework, impact of COVID-19, and market attractiveness index.
The growing animal healthcare expenditure and the rising demand for veterinary specialization, are opportunities that can be leveraged by the market to reach the anticipated growth during the projected phase. However, the adverse effects of post-vaccination and an inadequate number of veterinarians, are restricting the studied market’s development. Moreover, the high cost of animal vaccines and stringent protocols are significant challenges faced by the veterinary medicines market.
Key geographies covered in the veterinary medicines market are:
• North America: Canada and United States
• Europe: Germany, United Kingdom, Spain, Italy, Russia, France, and Rest of Europe
• Asia-Pacific: Japan, China, India, South Korea, ASEAN countries, New Zealand & Australia, and Rest of Asia-Pacific
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: Turkey, Saudi Arabia, South Africa, the United Arab Emirates, and Rest of Middle East & Africa
The segmentation analysis of the veterinary medicines market includes:
• Market by Animal Type
o Companion Animals
o Livestock Animals
• Market by Distribution Channel
o Retail Veterinary Pharmacies
o Veterinary Hospital Pharmacies
• Market by Route of Administration
o Parenteral Route
o Oral Route
o Topical Route
• Market by Product
o Drugs
• Anti-infective
• Anti-inflammatory
• Parasiticide
o Vaccines
• Inactivated vaccines
• Attenuated vaccines
• Recombinant vaccines
o Medicated Feed Additives
• Antibiotics
• Amino acids
The renowned companies engaged in the veterinary medicines market are Ceva Sante Animale, Neogen Corporation, Evonik Industries AG, Hester Biosciences Limited, Kindred Biosciences, Elanco, Indian Immunologicals Limited, Virbac SA, Merck & Co, Biogenesis Bago SA, Dechra Pharmaceuticals Plc, Boehringer Ingelheim Animal Health GmbH, Vetoquinol, Archer Daniels Midland, and Zoetis.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   GLOBAL VETERINARY MEDICINES MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1.  THREAT OF NEW ENTRANTS
2.2.2.  THREAT OF SUBSTITUTE PRODUCTS
2.2.3.  BARGAINING POWER OF BUYERS
2.2.4.  BARGAINING POWER OF SUPPLIERS
2.2.5.  THREAT OF COMPETITIVE RIVALRY
2.3. INDUSTRY COMPONENTS
2.4. LEGAL POLICY AND REGULATORY FRAMEWORK
2.5. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1.  RISE IN LIVESTOCK PRODUCTION
2.8.2.  SURGE IN VARIOUS MEDICAL CONDITIONS IN ANIMALS
2.8.3.  INCREASING OWNERSHIP OF PETS
2.9. MARKET RESTRAINTS
2.9.1.  ADVERSE EFFECTS OF POST-VACCINATION
2.9.2.  LACK OF ADEQUATE NUMBER OF VETERINARIANS
2.10.  MARKET OPPORTUNITIES
2.10.1. GROWING ANIMAL HEALTHCARE EXPENDITURE
2.10.2. INCREASING DEMAND FOR VETERINARY SPECIALIZATION
2.11. MARKET CHALLENGES
2.11.1. STRINGENT REGULATIONS
2.11.2. HIGH COST OF ANIMAL VACCINES
3.   GLOBAL VETERINARY MEDICINES MARKET OUTLOOK - BY ANIMAL TYPE
3.1. COMPANION ANIMALS
3.2. LIVESTOCK ANIMALS
4.   GLOBAL VETERINARY MEDICINES MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
4.1. RETAIL VETERINARY PHARMACIES
4.2. VETERINARY HOSPITAL PHARMACIES
5.   GLOBAL VETERINARY MEDICINES MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
5.1. PARENTERAL ROUTE
5.2. ORAL ROUTE
5.3. TOPICAL ROUTE
6.   GLOBAL VETERINARY MEDICINES MARKET OUTLOOK - BY PRODUCT
6.1. DRUGS
6.1.1.  ANTI-INFECTIVE
6.1.2.  ANTI-INFLAMMATORY
6.1.3.  PARASITICIDE
6.2. VACCINES
6.2.1.  INACTIVATED VACCINES
6.2.2.  ATTENUATED VACCINES
6.2.3.  RECOMBINANT VACCINES
6.3. MEDICATED FEED ADDITIVES
6.3.1.  ANTIBIOTICS
6.3.2.  AMINO ACIDS
7.   GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1.  MARKET BY ANIMAL TYPE
7.1.2.  MARKET BY DISTRIBUTION CHANNEL
7.1.3.  MARKET BY ROUTE OF ADMINISTRATION
7.1.4.  MARKET BY PRODUCT
7.1.4.1.     MARKET BY DRUGS TYPE
7.1.4.2.     MARKET BY VACCINES TYPE
7.1.4.3.     MARKET BY MEDICATED FEED ADDITIVES TYPE
7.1.5.  COUNTRY ANALYSIS
7.1.5.1.     UNITED STATES
7.1.5.2.     CANADA
7.2. EUROPE
7.2.1.  MARKET BY ANIMAL TYPE
7.2.2.  MARKET BY DISTRIBUTION CHANNEL
7.2.3.  MARKET BY ROUTE OF ADMINISTRATION
7.2.4.  MARKET BY PRODUCT
7.2.4.1.     MARKET BY DRUGS TYPE
7.2.4.2.     MARKET BY VACCINES TYPE
7.2.4.3.     MARKET BY MEDICATED FEED ADDITIVES TYPE
7.2.5.  COUNTRY ANALYSIS
7.2.5.1.     GERMANY
7.2.5.2.     FRANCE
7.2.5.3.     UNITED KINGDOM
7.2.5.4.     ITALY
7.2.5.5.     RUSSIA
7.2.5.6.     SPAIN
7.2.5.7.     REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1.  MARKET BY ANIMAL TYPE
7.3.2.  MARKET BY DISTRIBUTION CHANNEL
7.3.3.  MARKET BY ROUTE OF ADMINISTRATION
7.3.4.  MARKET BY PRODUCT
7.3.4.1.     MARKET BY DRUGS TYPE
7.3.4.2.     MARKET BY VACCINES TYPE
7.3.4.3.     MARKET BY MEDICATED FEED ADDITIVES TYPE
7.3.5.  COUNTRY ANALYSIS
7.3.5.1.     CHINA
7.3.5.2.     JAPAN
7.3.5.3.     AUSTRALIA & NEW ZEALAND
7.3.5.4.     INDIA
7.3.5.5.     SOUTH KOREA
7.3.5.6.     ASEAN COUNTRIES
7.3.5.7.     REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1.  MARKET BY ANIMAL TYPE
7.4.2.  MARKET BY DISTRIBUTION CHANNEL
7.4.3.  MARKET BY ROUTE OF ADMINISTRATION
7.4.4.  MARKET BY PRODUCT
7.4.4.1.     MARKET BY DRUGS TYPE
7.4.4.2.     MARKET BY VACCINES TYPE
7.4.4.3.     MARKET BY MEDICATED FEED ADDITIVES TYPE
7.4.5.  COUNTRY ANALYSIS
7.4.5.1.     BRAZIL
7.4.5.2.     MEXICO
7.4.5.3.     REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1.  MARKET BY ANIMAL TYPE
7.5.2.  MARKET BY DISTRIBUTION CHANNEL
7.5.3.  MARKET BY ROUTE OF ADMINISTRATION
7.5.4.  MARKET BY PRODUCT
7.5.4.1.     MARKET BY DRUGS TYPE
7.5.4.2.     MARKET BY VACCINES TYPE
7.5.4.3.     MARKET BY MEDICATED FEED ADDITIVES TYPE
7.5.5.  COUNTRY ANALYSIS
7.5.5.1.     SAUDI ARABIA
7.5.5.2.     UNITED ARAB EMIRATES
7.5.5.3.     TURKEY
7.5.5.4.     SOUTH AFRICA
7.5.5.5.     REST OF MIDDLE EAST & AFRICA
8.   COMPANY PROFILES
8.1. EVONIK INDUSTRIES AG (RAG STIFTUNG)
8.2. INDIAN IMMUNOLOGICALS LIMITED
8.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
8.4. MERCK & CO
8.5. ZOETIS
8.6. BIOGENESIS BAGO SA
8.7. VETOQUINOL (SOPARFIN SCA)
8.8. ARCHER DANIELS MIDLAND
8.9. CEVA SANTE ANIMALE
8.10. VIRBAC SA
8.11. DECHRA PHARMACEUTICALS PLC
8.12. NEOGEN CORPORATION
8.13. ELANCO
8.14. HESTER BIOSCIENCES LIMITED
8.15. KINDRED BIOSCIENCES
9.   RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1.  OBJECTIVES OF STUDY
9.1.2.  SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1.  PRIMARY DATA SOURCES
9.2.2.  SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1.  EVALUATION OF PROPOSED MARKET
9.3.2.  IDENTIFICATION OF DATA SOURCES
9.3.3.  ASSESSMENT OF MARKET DETERMINANTS
9.3.4.  DATA COLLECTION
9.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE 2: NUMBER OF HOUSEHOLDS OWNING PETS IN THE UNITED STATES (IN MILLION)
TABLE 3: GLOBAL VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 7: GLOBAL DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 18: EUROPE VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 19: EUROPE VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 20: EUROPE VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 21: EUROPE VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 22: EUROPE DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 23: EUROPE VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 24: EUROPE MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 25: EUROPE VETERINARY MEDICINES, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 35: LATIN AMERICA VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND AFRICA DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND AFRICA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND AFRICA MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 49: MIDDLE EAST AND AFRICA VETERINARY VACCINE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: GLOBAL VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 3: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 4: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 5: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
FIGURE 10: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
FIGURE 11: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
FIGURE 12: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 14: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 15: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 16: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
FIGURE 18: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 19: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
FIGURE 20: UNITED STATES VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 21: CANADA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 22: GERMANY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 23: FRANCE VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 25: ITALY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 26: RUSSIA VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)
FIGURE 27: SPAIN VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)
FIGURE 29: CHINA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 30: JAPAN VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 31: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 32: INDIA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 33: SOUTH KOREA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 34: ASEAN COUNTRIES’ VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 35: REST OF ASIA-PACIFIC VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 36: BRAZIL VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 37: MEXICO VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 38: REST OF LATIN AMERICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 39: SAUDI ARABIA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 40: UNITED ARAB EMIRATES VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 41: TURKEY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 42: SOUTH AFRICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 43: REST OF MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)